Tuesday, 30 June 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 30 June 2026
Ascott 1
Ascott 1
Latest News
J&J argues against 'far greater evil'

Johnson & Johnson is expecting low participation in an Australian class action against it, telling the Federal Court it would be 'evil' to allow costs to blow out to $40M ahead of a much lower potential settlement

Six Aussie Country Leaders in limbo
A spate of departures from country leadership roles across ANZ has left six top operators in limbo and a number of job openings
TODAY
'Policy lag tax' hurting patients
The true cost of policy delays is costing patients and the payment due is far more expensive than cash dollars
TODAY
Medscape
Medscape
Most Popular
The PBS at its best, Mark. Really?
The Health Minister has curiously used a therapy that took almost five years to reach patients as an example of the PBS at its best
29 June
10 drugs score July PBS listings
The 10 PBS listings announced by Butler includes 2 new labels for one drug, and a drug yet to be recommended by the PBAC
29 June
Two days, two big deals for Arrotex
Company steams on, signing yet another deal - this time bringing an innovative medicine to ANZ in a space dominated by Big Pharmas
26 June
Aussie redundancies keep piling up
ICYMI: Another Big Pharma has announced it's downsizing its local team plus the other top stories this week
26 June Your Week in 5 Minutes
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (22)

Access & Reimbursement (2)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (6)

Executive Roles (5)

Other (11)

More News
Troubled drug faces revocation
Concerns over a registrational trial have seen overseas authorities recommend removing approval for this PBS-listed drug
TODAY
TGA win lands just in time
This company has earned the regulator's nod for a drug which will be considered by the PBAC when it meets early next month
TODAY
Double PBS win for Novo
Two long-awaited drugs to join the scheme - one recommended by the PBAC three years ago and another TGA approved in 2017
29 June
NEXT-level Summit agenda reveal
The Day 1 Agenda for NEXT Pharma Summit Australia is out promising a no-holds-barred deep dive into the state of the industry
29 June
$59M drug under threat
The TGA has approved two new meds plus the first generics of two drugs - one which made over $59M on the PBS last year
29 June Approvals Action
Pharma's feeling slightly less gloomy
Despite unrelenting headwinds the industry's mood is improving, inching away from negative sentiment into neutral territory
26 June
Why pharma strategies are failing
The gap between strategic intent and execution is widening as demand for transformation grows faster than leadership capacity
26 June
Look who's moving its HQ to the US
Australian radiopharma is setting up its global headquarters in Boston as it takes on the big guns, including Novartis
26 June
Lilly says 'No' to Aussie drug launch
This new drug will not reach Aust in the foreseeable future as Lilly continues its stance against the nation's reimbursement system
25 June
Arrotex inks first-to-market deal
Arrotex has lost its CEO, but the deals keep coming with an exclusive agreement to bring first-to-market therapy eye to Australia
25 June
Pharma joins Ebola fight
Companies step up efforts to battle the deadly disease with WHO announcing two drugs will be trialled from next week
25 June
Companies eye monster market
With a trump card in the form of a superior safety profile, this partnership is ready to crack a lucrative market
25 June
Aussie drug heads to LA
A promising new cancer treatment developed by Aussie researchers has been acquired for an undisclosed price
25 June
Second ANZ Leader resigns in 24 hours
A local GM has decided to seek other opportunities rather than take up an expanded role in a restructured company
24 June
PiF Advertise
PiF Advertise
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe